✦ LIBER ✦

DOP069 Tripeptide KdPT ameliorates intestinal inflammation in patients with mild to moderate active ulcerative colitis

✍ Scribed by Kucharzik, T.; Lemmnitz, G.; Abels, C.; Maaser, C.

Book ID: 122254089
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 122 KB
Volume: 8
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(14)60094-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1216 Tripeptide KDPT Accelerates Disea

Mo1216 Tripeptide KDPT Accelerates Disease Remission in Patients With Mild to Moderate Active Ulcerative Colitis

✍ Kucharzik, Torsten; Lemmnitz, Gunter; Abels, Christoph; Maaser, Christian 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 218 KB

SUPPLEMENTATION WITH THE PROBIOTIC VSL#3

SUPPLEMENTATION WITH THE PROBIOTIC VSL#3 IN PATIENTS WITH MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY

✍ A. Tursi; A. Papa; G. Brandimarte; A. Giglio; W. Elisei; G.M. Giorgetti; G. Fort 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

388 Supplementation with the Probiotic V

388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study

✍ Antonio Tursi; Giovanni Brandimarte; Alfredo Papa; Andrea Giglio; Walter Elisei; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

✍ P. R. GIBSON; B. FIXA; B. PEKÁRKOVÁ; M. BÁTOVSKÝ; G. RADFORD-SMITH; J. TIBITANZL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Sa1219 Efficacy of Budesonide MMx® in Re

Sa1219 Efficacy of Budesonide MMx® in Reduction of Symptoms in Patients With Mild-to-Moderately Active Ulcerative Colitis: A Pooled Analysis of the CORE I and CORE II Studies

✍ Sandborn, William; Hardiman, Yun; Huang, Michael; Harris-Collazo, Raul; Ballard, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Safety and tolerability of a modified fi

Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot